Here's what Leo said to Cabel.
"Does Adam know that Cellceutix did a Phase 2b study for ABSSSI with approval from the FDA? That was long after Polymedix went bankrupt. The results of the US Phase 2b have been extensively disclosed and had a far superior safety profile than Polymedix's Phase 2a conducted in Russia and Ukraine. It seems he is focused on Polymedix results.
Also regarding the 42 days of enema....the results we are achieving in UP is Brilacidin in water. A foam formulation is planned and would be expected to improve results even more!
See the following information on Uceris. We have reviewed their results and have spoken to many GI Physicians. We plan to go head to head against them in a future trial."
"Does Adam know that Cellceutix did a Phase 2b study for ABSSSI with approval from the FDA? That was long after Polymedix went bankrupt. The results of the US Phase 2b have been extensively disclosed and had a far superior safety profile than Polymedix's Phase 2a conducted in Russia and Ukraine. It seems he is focused on Polymedix results.
Also regarding the 42 days of enema....the results we are achieving in UP is Brilacidin in water. A foam formulation is planned and would be expected to improve results even more!
See the following information on Uceris. We have reviewed their results and have spoken to many GI Physicians. We plan to go head to head against them in a future trial."
4
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
